Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 279

1.

Characteristics of motor dysfunction in longstanding HIV.

Robinson-Papp J, Gensler G, Navis A, Sherman S, Ellis RJ, Gelman BB, Kolson DL, Letendre SL, Singer EJ, Valdes-Sueiras M, Morgello S; National NeuroAIDS Tissue Consortium.

Clin Infect Dis. 2019 Oct 7. pii: ciz986. doi: 10.1093/cid/ciz986. [Epub ahead of print]

PMID:
31587032
2.

Use of Neuroimaging to Inform Optimal Neurocognitive Criteria for Detecting HIV-Associated Brain Abnormalities.

Campbell LM, Fennema-Notestine C, Saloner R, Hussain M, Chen A, Franklin D, Umlauf A, Ellis RJ, Collier AC, Marra CM, Clifford DB, Gelman BB, Sacktor N, Morgello S, McCutchan JA, Letendre S, Grant I, Heaton RK; CHARTER Group.

J Int Neuropsychol Soc. 2019 Oct 2:1-16. doi: 10.1017/S1355617719000985. [Epub ahead of print]

PMID:
31576785
3.

Switching to Tenofovir Alafenamide in Elvitegravir-Based Regimens: Pharmacokinetics and Antiviral Activity in Cerebrospinal Fluid.

Ma Q, Ocque AJ, Morse GD, Sanders C, Burgi A, Little SJ, Letendre SL.

Clin Infect Dis. 2019 Sep 27. pii: ciz926. doi: 10.1093/cid/ciz926. [Epub ahead of print]

PMID:
31560741
4.

Better executive function is independently associated with full HIV suppression during combination therapy.

Anderson AM, Pérez-Santiago J, Zheng Z, Huang E, Franklin D, Iudicello J, Moore DJ, Ellis RJ, Heaton RK, Letendre SL.

AIDS. 2019 Aug 20. doi: 10.1097/QAD.0000000000002348. [Epub ahead of print]

PMID:
31436611
5.

Plasma CXCL10 correlates with HAND in HIV-infected women.

Burlacu R, Umlauf A, Marcotte TD, Soontornniyomkij B, Diaconu CC, Bulacu-Talnariu A, Temereanca A, Ruta SM, Letendre S, Ene L, Achim CL.

J Neurovirol. 2019 Aug 14. doi: 10.1007/s13365-019-00785-4. [Epub ahead of print]

PMID:
31414350
6.

Frailty in medically complex individuals with chronic HIV.

Morgello S, Gensler G, Sherman S, Ellis RJ, Gelman BB, Kolson DL, Letendre SL, Robinson-Papp J, Rubin LH, Singer E, Valdes-Sueiras M; NNTC.

AIDS. 2019 Aug 1;33(10):1603-1611. doi: 10.1097/QAD.0000000000002250.

PMID:
31305330
7.

Frailty in Comorbid HIV and Lifetime Methamphetamine Use Disorder: Associations with Neurocognitive and Everyday Functioning.

Paolillo EW, Saloner R, Montoya JL, Campbell LM, Pasipanodya EC, Iudicello JE, Moore RC, Letendre SL, Jeste DV, Moore DJ.

AIDS Res Hum Retroviruses. 2019 Aug 12. doi: 10.1089/AID.2019.0062. [Epub ahead of print]

PMID:
31303012
8.

Plasma (1 → 3)-β-D-glucan and suPAR levels correlate with neurocognitive performance in people living with HIV on antiretroviral therapy: a CHARTER analysis.

Gianella S, Letendre SL, Iudicello J, Franklin D, Gaufin T, Zhang Y, Porrachia M, Vargas-Meneses M, Ellis RJ, Finkelman M, Hoenigl M.

J Neurovirol. 2019 Jul 11. doi: 10.1007/s13365-019-00775-6. [Epub ahead of print]

PMID:
31297727
9.

Blood amyloid-β protein isoforms are affected by HIV-1 in a subtype-dependent pattern.

de Almeida SM, Ribeiro CE, Rotta I, Letendre S, Potter M, Tang B, Batistela M, Vaida F, Ellis RJ; HIV Neurobehavioral Research Center (HNRC) Group.

J Neurovirol. 2019 Jul 7. doi: 10.1007/s13365-019-00783-6. [Epub ahead of print]

PMID:
31281948
10.

Iron-regulatory genes are associated with Neuroimaging measures in HIV infection.

Fennema-Notestine C, Thornton-Wells TA, Hulgan T, Letendre S, Ellis RJ, Franklin DR Jr, Anderson AM, Heaton RK, Bloss CS, Grant I, Kallianpur AR; CHARTER Study Group.

Brain Imaging Behav. 2019 Jul 3. doi: 10.1007/s11682-019-00153-0. [Epub ahead of print]

PMID:
31273671
11.

Mitochondrial biogenesis is altered in HIV+ brains exposed to ART: Implications for therapeutic targeting of astroglia.

Swinton MK, Carson A, Telese F, Sanchez AB, Soontornniyomkij B, Rad L, Batki I, Quintanilla B, Pérez-Santiago J, Achim CL, Letendre S, Ellis RJ, Grant I, Murphy AN, Fields JA.

Neurobiol Dis. 2019 Oct;130:104502. doi: 10.1016/j.nbd.2019.104502. Epub 2019 Jun 22.

PMID:
31238091
12.

Linked CSF reduction of phosphorylated tau and IL-8 in HIV associated neurocognitive disorder.

Ozturk T, Kollhoff A, Anderson AM, Christina Howell J, Loring DW, Waldrop-Valverde D, Franklin D, Letendre S, Tyor WR, Hu WT.

Sci Rep. 2019 Jun 19;9(1):8733. doi: 10.1038/s41598-019-45418-2.

13.

Correlates of HIV RNA concentrations in cerebrospinal fluid during antiretroviral therapy: a longitudinal cohort study.

Livelli A, Vaida F, Ellis RJ, Ma Q, Ferrara M, Clifford DB, Collier AC, Gelman BB, Marra CM, McArthur JC, McCutchan JA, Morgello S, Sacktor N, Simpson DM, Grant I, Letendre SL; CHARTER Group.

Lancet HIV. 2019 Jul;6(7):e456-e462. doi: 10.1016/S2352-3018(19)30143-2. Epub 2019 Jun 14.

14.

CROI 2019: neurologic complications of HIV disease.

Ances BM, Letendre SL.

Top Antivir Med. 2019 Apr;27(1):26-33. Review.

15.

Cognitive Trajectory Phenotypes in Human Immunodeficiency Virus-Infected Patients.

Dastgheyb RM, Sacktor N, Franklin D, Letendre S, Marcotte T, Heaton R, Grant I, McArthur JC, Rubin LH, Haughey NJ.

J Acquir Immune Defic Syndr. 2019 Sep 1;82(1):61-70. doi: 10.1097/QAI.0000000000002093.

PMID:
31107302
16.

Collaborative Action on Fetal Alcohol Spectrum Disorder Prevention: Principles for Enacting the Truth and Reconciliation Commission Call to Action #33.

Wolfson L, Poole N, Morton Ninomiya M, Rutman D, Letendre S, Winterhoff T, Finney C, Carlson E, Prouty M, McFarlane A, Ruttan L, Murphy L, Stewart C, Lawley L, Rowan T.

Int J Environ Res Public Health. 2019 May 7;16(9). pii: E1589. doi: 10.3390/ijerph16091589.

17.

Catechol-O-methyltransferase polymorphism Val158Met is associated with distal neuropathic pain in HIV-associated sensory neuropathy.

Xu J, Umlauf A, Letendre S, Franklin D, Bush WS, Atkinson JH, Keltner J, Ellis RJ.

AIDS. 2019 Aug 1;33(10):1575-1582. doi: 10.1097/QAD.0000000000002240.

PMID:
31021849
18.

Posttraumatic Stress Disorder and Neurocognitive Impairment in a U.S. Military Cohort of Persons Living with HIV.

Deiss R, Campbell CJ, Watson CW, Moore RC, Crum-Cianflone NF, Wang X, Ganesan A, Okulicz LCJ, Letendre S, Maves RC, Moore DJ, Agan BK.

Psychiatry. 2019 Fall;82(3):228-239. doi: 10.1080/00332747.2019.1586503. Epub 2019 Mar 29.

PMID:
30925113
19.

Neurocognitive SuperAging in Older Adults Living With HIV: Demographic, Neuromedical and Everyday Functioning Correlates.

Saloner R, Campbell LM, Serrano V, Montoya JL, Pasipanodya E, Paolillo EW, Franklin D, Ellis RJ, Letendre SL, Collier AC, Clifford DB, Gelman BB, Marra CM, McCutchan JA, Morgello S, Sacktor N, Jeste DV, Grant I, Heaton RK, Moore DJ; CHARTER and HNRP Groups.

J Int Neuropsychol Soc. 2019 May;25(5):507-519. doi: 10.1017/S1355617719000018. Epub 2019 Mar 20.

20.

Depression and aging with HIV: Associations with health-related quality of life and positive psychological factors.

Rooney AS, Moore RC, Paolillo EW, Gouaux B, Umlauf A, Letendre SL, Jeste DV, Moore DJ; HIV Neurobehavioral Research Program.

J Affect Disord. 2019 May 15;251:1-7. doi: 10.1016/j.jad.2019.03.025. Epub 2019 Mar 6.

PMID:
30884371
21.

Effects of comorbidity burden and age on brain integrity in HIV.

Saloner R, Heaton RK, Campbell LM, Chen A, Franklin D Jr, Ellis RJ, Collier AC, Marra C, Clifford DB, Gelman B, Sacktor N, Morgello S, McCutchan JA, Letendre S, Grant I, Fennema-Notestine C; CHARTER Study Group.

AIDS. 2019 Jun 1;33(7):1175-1185. doi: 10.1097/QAD.0000000000002192.

PMID:
30870195
22.

Impaired insulin sensitivity is associated with worsening cognition in HIV-infected patients.

Khuder SS, Chen S, Letendre S, Marcotte T, Grant I, Franklin D, Rubin LH, Margolick JB, Jacobson LP, Sacktor N, D'Souza G, Stosor V, Lake JE, Rapocciolo G, McArthur JC, Dickens AM, Haughey NJ.

Neurology. 2019 Mar 19;92(12):e1344-e1353. doi: 10.1212/WNL.0000000000007125. Epub 2019 Feb 20.

PMID:
30787163
23.

Cerebrospinal fluid viral escape in aviremic HIV-infected patients receiving antiretroviral therapy: prevalence, risk factors and neurocognitive effects.

Pérez-Valero I, Ellis R, Heaton R, Deutsch R, Franklin D, Clifford DB, Collier A, Gelman B, Marra C, McCutchan JA, Navis A, Sacktor N, Simpson D, Grant I, Letendre S.

AIDS. 2019 Mar 1;33(3):475-481. doi: 10.1097/QAD.0000000000002074.

PMID:
30702516
24.

Peripheral Blood Mitochondrial DNA Copy Number Obtained From Genome-Wide Genotype Data Is Associated With Neurocognitive Impairment in Persons With Chronic HIV Infection.

Hulgan T, Kallianpur AR, Guo Y, Barnholtz-Sloan JS, Gittleman H, Brown TT, Ellis R, Letendre S, Heaton RK, Samuels DC; CHARTER Study.

J Acquir Immune Defic Syndr. 2019 Apr 1;80(4):e95-e102. doi: 10.1097/QAI.0000000000001930.

PMID:
30531306
25.

Comparison of bead array and glass nanoreactor multi-analyte platforms for the evaluation of CNS and peripheral inflammatory markers during HIV infection.

Anderson AM, Nguyen ML, Potter M, Rosario D, Kempinska K, Ellis RJ, Diccianni M, Letendre SL.

J Immunol Methods. 2019 Feb;465:7-12. doi: 10.1016/j.jim.2018.11.008. Epub 2018 Nov 20.

PMID:
30468733
26.

Psychosocial Correlates of Frailty Among HIV-Infected and HIV-Uninfected Adults.

Rubtsova AA, Marquine MJ, Depp C, Holstad M, Ellis RJ, Letendre S, Jeste DV, Moore DJ.

Behav Med. 2019 Jul-Sep;45(3):210-220. doi: 10.1080/08964289.2018.1509053. Epub 2018 Nov 15.

PMID:
30431403
27.

Brief Report: Body Mass Index and Cognitive Function Among HIV-1-Infected Individuals in China, India, and Nigeria.

Jumare J, El-Kamary SS, Magder L, Hungerford L, Umlauf A, Franklin D, Ghate M, Abimiku A, Charurat M, Letendre S, Ellis RJ, Mehendale S, Blattner WA, Royal W 3rd, Marcotte TD, Heaton RK, Grant I, McCutchan JA.

J Acquir Immune Defic Syndr. 2019 Feb 1;80(2):e30-e35. doi: 10.1097/QAI.0000000000001906.

PMID:
30422905
28.

Effects of trauma, economic hardship, and stress on neurocognition and everyday function in HIV.

Watson CW, Sundermann EE, Hussain MA, Umlauf A, Thames AD, Moore RC, Letendre SL, Jeste DV, Morgan EE, Moore DJ.

Health Psychol. 2019 Jan;38(1):33-42. doi: 10.1037/hea0000688. Epub 2018 Oct 29.

PMID:
30372103
29.

Inflammation Relates to Poorer Complex Motor Performance Among Adults Living With HIV on Suppressive Antiretroviral Therapy.

Montoya JL, Campbell LM, Paolillo EW, Ellis RJ, Letendre SL, Jeste DV, Moore DJ.

J Acquir Immune Defic Syndr. 2019 Jan 1;80(1):15-23. doi: 10.1097/QAI.0000000000001881.

PMID:
30365450
30.

Effects of HIV Infection, methamphetamine dependence and age on cortical thickness, area and volume.

MacDuffie KE, Brown GG, McKenna BS, Liu TT, Meloy MJ, Tawa B, Archibald S, Fennema-Notestine C, Atkinson JH Jr, Ellis RJ, Letendre SL, Hesselink JR, Cherner M, Grant I; TMARC Group.

Neuroimage Clin. 2018;20:1044-1052. doi: 10.1016/j.nicl.2018.09.034. Epub 2018 Oct 7.

31.

White matter damage, neuroinflammation, and neuronal integrity in HAND.

Alakkas A, Ellis RJ, Watson CW, Umlauf A, Heaton RK, Letendre S, Collier A, Marra C, Clifford DB, Gelman B, Sacktor N, Morgello S, Simpson D, McCutchan JA, Kallianpur A, Gianella S, Marcotte T, Grant I, Fennema-Notestine C; CHARTER Group.

J Neurovirol. 2019 Feb;25(1):32-41. doi: 10.1007/s13365-018-0682-9. Epub 2018 Oct 5.

32.

Cerebrospinal Fluid Ceruloplasmin, Haptoglobin, and Vascular Endothelial Growth Factor Are Associated with Neurocognitive Impairment in Adults with HIV Infection.

Kallianpur AR, Gittleman H, Letendre S, Ellis R, Barnholtz-Sloan JS, Bush WS, Heaton R, Samuels DC, Franklin DR Jr, Rosario-Cookson D, Clifford DB, Collier AC, Gelman B, Marra CM, McArthur JC, McCutchan JA, Morgello S, Grant I, Simpson D, Connor JR, Hulgan T; CHARTER Study Group.

Mol Neurobiol. 2019 May;56(5):3808-3818. doi: 10.1007/s12035-018-1329-9. Epub 2018 Sep 12.

PMID:
30209774
33.

Transient and asymptomatic meningitis in human immunodeficiency virus-1 subtype C: a case study of genetic compartmentalization and biomarker dynamics.

de Almeida SM, Oliveira MF, Chaillon A, Rotta I, Ribeiro CE, de Pereira AP, Smith D, Letendre S, Ellis RJ.

J Neurovirol. 2018 Dec;24(6):786-796. doi: 10.1007/s13365-018-0672-y. Epub 2018 Sep 7.

34.

Neurofilament light chain in blood is negatively associated with neuropsychological performance in HIV-infected adults and declines with initiation of antiretroviral therapy.

Anderson AM, Easley KA, Kasher N, Franklin D, Heaton RK, Zetterberg H, Blennow K, Gisslen M, Letendre SL.

J Neurovirol. 2018 Dec;24(6):695-701. doi: 10.1007/s13365-018-0664-y. Epub 2018 Aug 13.

PMID:
30105502
35.

Nuclear-Mitochondrial interactions influence susceptibility to HIV-associated neurocognitive impairment.

Smieszek S, Jia P, Samuels DC, Zhao Z, Barnholtz-Sloan J, Kaur H, Letendre S, Ellis R, Franklin DR, Hulgan T, Kallianpur A, Bush WS; CHARTER Study Group.

Mitochondrion. 2019 May;46:247-255. doi: 10.1016/j.mito.2018.07.004. Epub 2018 Jul 17.

36.

Association of antiretroviral therapy with brain aging changes among HIV-infected adults.

Soontornniyomkij V, Umlauf A, Soontornniyomkij B, Gouaux B, Ellis RJ, Levine AJ, Moore DJ, Letendre SL.

AIDS. 2018 Sep 10;32(14):2005-2015. doi: 10.1097/QAD.0000000000001927.

37.

Neurocognitive functioning predicts frailty index in HIV.

Oppenheim H, Paolillo EW, Moore RC, Ellis RJ, Letendre SL, Jeste DV, Grant I, Moore DJ; HIV Neurobehavioral Research Program (HNRP).

Neurology. 2018 Jul 10;91(2):e162-e170. doi: 10.1212/WNL.0000000000005761. Epub 2018 Jun 6.

38.

A composite of multisystem injury and neurocognitive impairment in HIV infection: association with everyday functioning.

Marquine MJ, Flores I, Kamat R, Johnson N, Umlauf A, Letendre S, Jeste D, Grant I, Moore D, Heaton RK.

J Neurovirol. 2018 Oct;24(5):549-556. doi: 10.1007/s13365-018-0643-3. Epub 2018 May 17.

39.

Development and validation of an LC-MS/MS assay for tenofovir and tenofovir alafenamide in human plasma and cerebrospinal fluid.

Ocque AJ, Hagler CE, Morse GD, Letendre SL, Ma Q.

J Pharm Biomed Anal. 2018 Jul 15;156:163-169. doi: 10.1016/j.jpba.2018.04.035. Epub 2018 Apr 23.

40.

Incidence of symptomatic CSF viral escape in HIV infected patients receiving atazanavir/ritonavir (ATV/r)-containing ART: a tertiary care cohort in western India.

Patel AK, Patel KK, Gohel S, Kumar A, Letendre S.

J Neurovirol. 2018 Aug;24(4):498-505. doi: 10.1007/s13365-018-0642-4. Epub 2018 Apr 24.

41.

HIV, prospective memory, and cerebrospinal fluid concentrations of quinolinic acid and phosphorylated Tau.

Anderson AM, Croteau D, Ellis RJ, Rosario D, Potter M, Guillemin GJ, Brew BJ, Woods SP, Letendre SL.

J Neuroimmunol. 2018 Jun 15;319:13-18. doi: 10.1016/j.jneuroim.2018.03.007. Epub 2018 Mar 18.

42.

Impact of Antiretroviral Regimens on Cerebrospinal Fluid Viral Escape in a Prospective Multicohort Study of Antiretroviral Therapy-Experienced Human Immunodeficiency Virus-1-Infected Adults in the United States.

Mukerji SS, Misra V, Lorenz DR, Uno H, Morgello S, Franklin D, Ellis RJ, Letendre S, Gabuzda D.

Clin Infect Dis. 2018 Sep 28;67(8):1182-1190. doi: 10.1093/cid/ciy267.

43.

Neurocognitive impairment with hepatitis C and HIV co-infection in Southern Brazil.

de Almeida SM, de Pereira AP, Pedroso MLA, Ribeiro CE, Rotta I, Tang B, Umlauf A, Franklin D, Saloner RG, Batista MGR, Letendre S, Heaton RK, Ellis RJ, Cherner M; HNRC Group.

J Neurovirol. 2018 Jun;24(3):339-349. doi: 10.1007/s13365-018-0617-5. Epub 2018 Mar 7.

44.

Higher Anti-Cytomegalovirus Immunoglobulin G Concentrations Are Associated With Worse Neurocognitive Performance During Suppressive Antiretroviral Therapy.

Letendre S, Bharti A, Perez-Valero I, Hanson B, Franklin D, Woods SP, Gianella S, de Oliveira MF, Heaton RK, Grant I, Landay AL, Lurain N; CNS HIV AntiRetroviral Therapy Effects Research (CHARTER) Group.

Clin Infect Dis. 2018 Aug 16;67(5):770-777. doi: 10.1093/cid/ciy170.

45.

Neprilysin in the Cerebrospinal Fluid and Serum of Patients Infected With HIV1-Subtypes C and B.

de Almeida SM, Tang B, Ribeiro CE, Rotta I, Vaida F, Piovesan M, Batistela Fernandes MS, Letendre S, Potter M, Ellis RJ; HIV Neurobehavioral Research Center (HNRC) Group.

J Acquir Immune Defic Syndr. 2018 Jun 1;78(2):248-256. doi: 10.1097/QAI.0000000000001666.

46.

Measurement of Human Immunodeficiency Virus p24 Antigen in Human Cerebrospinal Fluid With Digital Enzyme-Linked Immunosorbent Assay and Association With Decreased Neuropsychological Performance.

Anderson AM, Tyor WR, Mulligan MJ, Waldrop-Valverde D, Lennox JL, Letendre SL.

Clin Infect Dis. 2018 Jun 18;67(1):137-140. doi: 10.1093/cid/ciy056. Erratum in: Clin Infect Dis. 2018 Sep 28;67(8):1313.

47.

Positive Psychological Factors are Linked to Successful Cognitive Aging Among Older Persons Living with HIV/AIDS.

Moore DJ, Fazeli PL, Moore RC, Woods SP, Letendre SL, Jeste DV, Grant I; HIV Neurobehavioral Research Program.

AIDS Behav. 2018 May;22(5):1551-1561. doi: 10.1007/s10461-017-2001-5.

48.

Biomarkers of neuronal injury and amyloid metabolism in the cerebrospinal fluid of patients infected with HIV-1 subtypes B and C.

de Almeida SM, Ribeiro CE, Rotta I, Piovesan M, Tang B, Vaida F, Raboni SM, Letendre S, Potter M, Batistela Fernandes MS, Ellis RJ; HIV Neurobehavioral Research Center (HNRC) Group.

J Neurovirol. 2018 Feb;24(1):28-40. doi: 10.1007/s13365-017-0591-3. Epub 2017 Oct 23.

49.

Differences in Neurocognitive Impairment Among HIV-Infected Latinos in the United States.

Marquine MJ, Heaton A, Johnson N, Rivera-Mindt M, Cherner M, Bloss C, Hulgan T, Umlauf A, Moore DJ, Fazeli P, Morgello S, Franklin D, Letendre S, Ellis R, Collier AC, Marra CM, Clifford DB, Gelman BB, Sacktor N, Simpson D, McCutchan JA, Grant I, Heaton RK.

J Int Neuropsychol Soc. 2018 Feb;24(2):163-175. doi: 10.1017/S1355617717000832. Epub 2017 Sep 6.

50.

Personalized Risk Index for Neurocognitive Decline Among People With Well-Controlled HIV Infection.

Yuen T, Brouillette MJ, Fellows LK, Ellis RJ, Letendre S, Heaton R, Mayo N; CHARTER group,.

J Acquir Immune Defic Syndr. 2017 Sep 1;76(1):48-54. doi: 10.1097/QAI.0000000000001466.

PMID:
28797021

Supplemental Content

Loading ...
Support Center